Letter in response to C.W. van den Berg and B.P. Morgan: "Letter in response to A. Agrawal: CRP after 2004"

Molecular Immunology

Volumn 44, Issue 4, 2007, Pages 670-671

  Kushner, Irving ^a   Agrawal, Alok ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SODIUM AZIDE; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE HEART INFARCTION; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; HUMAN; LETTER; METABOLIC SYNDROME X; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT STRAIN; ANIMAL; APOPTOSIS; IMMUNOLOGY; INFLAMMATION; NOTE; RAT;

ANIMALS; APOPTOSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; RATS;

EID: 33747860603     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.02.001     Document Type: Letter

References (12)

1. Agrawal A. CRP after 2004. Mol. Immunol. 42 (2005) 927-930
2. Black S., Kushner I., and Samols D. C-reactive protein. J. Biol. Chem. 279 (2004) 48487-48490
3. Hingorani A., and Humphries S. Nature's randomized trials. Lancet 366 (2005) 1906-1908
4. Kushner I. Semantics, inflammation, cytokines and common sense. Cytokine Growth Factor Rev. 9 (1998) 191-196
5. Marnell L., Mold C., and Du Clos T.W. C-reactive protein: ligands, receptors and role in inflammation. Clin. Immunol. 117 (2005) 104-111
6. Mortensen R.F. C-reactive protein, inflammation, and innate immunity. Immunol. Res. 24 (2001) 163-176
7. Timpson N.J., Lawlor D.A., Harbord R.M., Gaunt T.R., Day I.N.M., Palmer L.J., Hattersley A.T., Ebrahim S., Lowe G.D.O., Rumley A., and Smith G.D. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366 (2005) 1954-1959
8. van den Berg C.W., and Morgan B.P. Letter in response to A. Agrawal: 'CRP after 2004'. Mol. Immunol. 43 (2006) 292-293
9. Verschuren L., Kleemann R., Offerman E.H., Szalai A.J., Emeis S.J., Princen H.M.G., and Kooistra T. Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-leiden transgenic mice. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 161-167
10. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38 (2001) 189-197
11. Volanakis J.E. Complement activation by C-reactive protein complexes. Ann. N.Y. Acad. Sci. 389 (1982) 235-250
12. Xia D., and Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2575-2580